Last 27 quarters of trend data · Healthcare · Healthcare Software & Telehealth
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -42.42 | — | — | 101.47 | 223.66 | 73.31 | 36.94 | 54.95 | 14.39 | 89.18 | 77.35 | 377.12 | — | — | — | — | — | — | — | — | — |
| — | — | — | +84.6% | +1454.2% | -17.8% | -52.2% | -85.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 2.25 | 2.67 | 1.95 | 3.26 | 5.89 | 5.87 | 3.11 | 3.02 | 2.70 | 3.75 | 3.19 | 1.89 | 1.46 | 2.36 | 2.69 | 1.98 | 1.98 | 2.03 | 2.67 | 3.89 | 5.08 |
| — | -54.6% | -37.3% | +7.8% | +118.4% | +56.4% | -2.5% | +59.8% | +84.9% | +59.4% | +18.4% | -4.2% | -26.3% | +15.8% | +1.0% | -49.3% | -61.1% | -76.4% | -72.5% | -44.2% | +100.8% | |
| P/B Ratio | 12.41 | 24.79 | 10.63 | 14.89 | 24.28 | 22.75 | 13.27 | 12.21 | 9.84 | 13.10 | 10.30 | 5.43 | 4.02 | 6.12 | 6.57 | 4.24 | 3.68 | 2.90 | 3.30 | 3.94 | 4.25 |
| — | +9.0% | -19.9% | +22.0% | +146.7% | +73.7% | +28.8% | +125.0% | +144.6% | +114.0% | +56.8% | +28.0% | +9.2% | +111.4% | +99.3% | +7.5% | -13.3% | -59.4% | -52.4% | — | — | |
| P/FCF | 64.53 | — | 22.35 | 2453.01 | 38.57 | — | 36.40 | 24.46 | 13.64 | 24.91 | 74.67 | 43.27 | 17.15 | 49.17 | 73.67 | — | 71.15 | — | — | — | — |
| — | — | -38.6% | +9929.9% | +182.9% | — | -51.3% | -43.5% | -20.5% | -49.3% | +1.4% | — | -75.9% | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | 257.59 | 82.00 | 126.18 | 85.51 | 26.74 | 56.90 | 39.02 | 78.76 | 66.93 | 197.07 | — | — | — | — | — | — | — | — | — |
| — | — | +863.4% | +44.1% | +223.4% | +8.6% | -60.1% | -71.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 63.36 | — | — | 121.88 | 304.29 | 96.80 | 29.25 | 62.93 | 44.25 | 86.09 | 69.64 | — | — | — | — | — | — | — | — | — | — |
| — | — | — | +93.7% | +587.7% | +12.4% | -58.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.8% | 63.8% | 49.4% | 71.9% | 73.8% | 76.4% | 73.5% | 76.8% | 79.2% | 81.3% | 82.4% | 82.7% | 82.6% | 81.8% | 80.4% | 79.1% | 79.0% | 76.8% | 73.8% | 73.3% | 74.0% |
| — | -16.4% | -32.8% | -6.3% | -6.8% | -6.0% | -10.8% | -7.2% | -4.2% | -0.7% | +2.4% | +4.5% | +4.6% | +6.6% | +9.0% | +8.0% | +6.8% | -1.5% | -4.1% | -4.7% | -2.3% | |
| Operating Margin | 4.5% | -12.9% | -2.7% | 1.5% | 2.0% | 4.9% | 9.9% | 3.9% | 5.6% | 3.5% | 3.6% | -0.2% | -3.8% | -4.4% | -5.9% | -6.9% | -13.8% | -17.8% | -16.7% | -25.5% | -37.3% |
| — | -363.1% | -127.4% | -61.5% | -64.6% | +40.4% | +177.5% | +2482.9% | +247.7% | +178.7% | +160.3% | +97.7% | +72.7% | +75.0% | +64.6% | +72.7% | +63.0% | +38.0% | +82.0% | -128.2% | -364.0% | |
| Net Margin | 5.5% | -11.5% | -15.1% | 3.3% | 2.6% | 7.8% | 8.4% | 5.4% | 18.8% | 4.2% | 4.0% | 0.5% | -3.3% | -3.4% | -5.3% | -6.5% | -13.0% | -17.3% | -16.0% | -36.8% | -21.5% |
| — | -246.8% | -279.4% | -38.4% | -86.0% | +85.2% | +111.1% | +971.5% | +663.9% | +222.4% | +175.8% | +107.7% | +74.3% | +80.1% | +67.1% | +82.3% | +39.5% | -14.9% | +83.7% | -191.7% | -51.3% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 25.2% | -22.4% | -18.7% | 3.7% | 2.8% | 7.6% | 9.6% | 5.7% | 18.8% | 3.8% | 3.2% | 0.4% | -2.3% | -2.3% | -3.2% | -3.5% | -6.0% | -6.1% | -4.9% | -9.0% | -4.9% |
| — | -393.1% | -293.5% | -35.3% | -85.4% | +103.1% | +198.4% | +1433.7% | +907.9% | +266.4% | +200.3% | +110.6% | +61.0% | +62.8% | +34.3% | +61.2% | -21.6% | -94.6% | +93.1% | — | — | |
| ROA | 9.0% | -2.9% | -4.2% | 0.9% | 0.8% | 3.1% | 6.2% | 4.0% | 14.0% | 2.9% | 2.5% | 0.3% | -1.9% | -1.9% | -2.7% | -2.9% | -4.9% | -5.2% | -4.0% | -7.4% | -4.2% |
| — | -195.4% | -167.3% | -76.4% | -94.5% | +7.2% | +147.3% | +1264.7% | +841.5% | +253.3% | +192.3% | +110.0% | +61.9% | +63.8% | +33.1% | +60.7% | -19.0% | -95.7% | +81.7% | -68.6% | +20.9% | |
| ROIC | 9.3% | -5.6% | -0.9% | 0.5% | 1.0% | 4.9% | 14.3% | 5.0% | 6.3% | 3.3% | 2.9% | -0.1% | -2.4% | -2.6% | -3.1% | -3.3% | -5.7% | -5.5% | -4.6% | -5.8% | -8.7% |
| — | -214.2% | -106.2% | -90.2% | -84.8% | +46.1% | +390.2% | +4572.8% | +364.0% | +227.5% | +193.3% | +96.6% | +57.8% | +52.1% | +31.7% | +43.2% | +34.8% | +18.2% | +98.1% | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.07 | 4.77 | 2.54 | 2.07 | 1.92 | 1.86 | 0.12 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | — |
| — | +157.1% | +2098.7% | +8605.0% | +7355.6% | +5754.7% | +236.2% | -17.7% | +81.1% | +99.3% | +118.9% | +69.9% | -22.0% | +5.4% | -0.2% | +3.9% | — | — | — | — | — | |
| Debt / EBITDA | 7.00 | — | 206.43 | 41.08 | 37.93 | 28.08 | 0.96 | 0.46 | 0.42 | 0.78 | 0.92 | 4.41 | — | — | — | — | — | — | — | — | — |
| — | — | +21450.8% | +8828.3% | +8835.5% | +3491.1% | +4.5% | -89.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 1.90 | 0.93 | 1.69 | 1.90 | 1.88 | 4.98 | 1.59 | 1.79 | 2.14 | 2.68 | 2.80 | 3.00 | 3.03 | 3.53 | 4.01 | 4.52 | 3.49 | 4.14 | 4.78 | 3.41 | 5.22 |
| — | -81.3% | +6.0% | +6.1% | -12.3% | +86.0% | -43.2% | -40.3% | -29.5% | -24.1% | -30.0% | -33.7% | -13.2% | -14.9% | -16.2% | +32.6% | -33.1% | -66.3% | -72.3% | -54.1% | -17.2% | |
| Quick Ratio | 1.61 | 0.87 | 1.55 | 1.61 | 1.64 | 4.46 | 1.32 | 1.50 | 1.82 | 2.30 | 2.48 | 2.74 | 2.76 | 3.20 | 3.64 | 4.07 | 3.16 | 3.79 | 4.53 | 3.24 | 5.02 |
| — | -80.4% | +17.4% | +7.7% | -9.7% | +93.6% | -46.8% | -45.4% | -34.3% | -28.1% | -31.7% | -32.6% | -12.5% | -15.5% | -19.7% | +25.7% | -37.0% | -68.6% | -73.4% | -55.0% | -16.6% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 27 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying HIMS stock.
Hims & Hers Health, Inc.'s current P/E is -42.4x. The average P/E over the last 2 quarters is 162.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Hims & Hers Health, Inc.'s current operating margin is 4.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Hims & Hers Health, Inc.'s business trajectory between earnings reports.